# Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

> **NCT00896701** · — · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 451 (actual)

## Conditions studied

- Leukemia

## Interventions

- **OTHER:** flow cytometry
- **OTHER:** immunologic technique
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00896701
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896701, "Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00896701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*